Explore E&L study challenges for key drug delivery formats and learn how these issues can be mitigated.

The risks and impact of potential extractable and leachable (E&L) substances on the human body are often underestimated. Additionally, the complexities of analytical methods, drug product formulations, and regulatory requirements often conflict, complicating a clear approach to E&L investigations. In this webinar, we will explore the main challenges a typical E&L study entails and present case studies focused on key drug delivery formats, such as inhaled and nasal drug products, to demonstrate how these issues can be resolved or mitigated.

Watch our webinar now:

Need help or have a question?

Intertek Switzerland Analytical Laboratory


Intertek (Schweiz) AG
TechCenter Reinach
Kägenstrasse 15
CH-4153 Reinach, Switzerland
T: +41 61 686 4800
E: business.support@intertek.com